Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Creative Bioarray Develops More Than 1000 Cell Types Together with Selective Cell Culture Media

    Nov 28, 2022, 15:36 PM by
    Full story
  • Creative Bioarray Releases GMP Grade Cytokines to Support Cell Manufacturing and Cell-based Therapies

    Nov 28, 2022, 15:35 PM by
    Full story
  • Acroscell Develops CiPA in Silico Modeling to Identify and Optimize Drug Candidates

    Nov 28, 2022, 15:34 PM by
    Full story
  • FDA Approved ADC Drugs list up to 2022

    Nov 28, 2022, 15:33 PM by
    Antibody-drug conjugates(ADCs) are use specific linkers to connect antibodies and small molecule cytotoxic drugs, and their main components include antibodies, linkers and small molecular cytotoxic drugs.
    Full story
  • Alfa Chemistry Strengthens Its Analytical Testing Business with A Diversified Product & Service Portfolio

    Nov 28, 2022, 15:32 PM by
    Analytical testing plays a pivotal role in nearly all fields and industries for quality and safety assurance. Fairly recently, the management team of Alfa Chemistry announced to further diversify its product & service portfolios, aiming to provide testing services as effectively and efficiently as possible to maximize customers' profits.
    Full story
  • Embracing Innovation–BOC Sciences Strengthens the Production of Cosmetics Ingredients

    Nov 28, 2022, 15:32 PM by
    It's verified by BOC Sciences officials that the critical specialty chemical distearyl phthalic acid amide is now in steady supply, aiming to accelerate the development of cosmetics industry.
    Full story
  • Insecticides and Metabolite Standards

    Nov 28, 2022, 15:27 PM by
    Full story
  • Polymer Characterization -- BOC Sciences

    Nov 28, 2022, 15:26 PM by
    Full story
  • NCC Group Monthly Threat Pulse – October 2022 - Ransomware attacks decrease but DDoS attacks on the rise

    Nov 28, 2022, 15:25 PM by
    Analysis from NCC Group’s Global Threat Intelligence team has revealed a decrease in ransomware attacks in October. However, there has been a notable shift in tactics, with more prevalent use of distributed denial of service (DDoS). In fact, October saw the highest number of DDoS incidents recorded this year.
    Full story
  • Optibrium appoints Ian Smith as Chief Technology Officer

    Nov 28, 2022, 15:18 PM by
    Optibrium appoints Ian Smith as Chief Technology Officer. New role will lead technology development as the Company continues to scale team and global business operations.
    Full story
  • PerkinElmer Helps Accelerate Gene Therapy Research with Industry-First Ready-to-Use Viral Vector Assays

    Nov 28, 2022, 15:18 PM by
    Latest assays in PerkinElmer's growing CGT portfolio
    Full story
  • Clinion Achieves GDPR Compliance – Strengthening patient data security

    Nov 28, 2022, 15:17 PM by
    https://clinioncdn.azureedge.net/wp-content/uploads/2022/11/GDPR_compliance_banner.jpg
    Full story
  • EMOTIV Partners with X-trodes to Launch New Medical-Grade, At-Home Solution for Brain Monitoring Research

    Nov 28, 2022, 15:17 PM by
    Wearable Electrode Patches Provide Unprecedented Accuracy for Researchers Measuring Brain and Physiological Signals Outside the Lab, Expanding Possibilities for Real-World Clinical Studies
    Full story
  • LIQUID STABLE & MULTI-ANALYTE CLINICAL REFERENCE MATERIALS FOR ELECTROLYTE TESTING AVAILABLE FROM VERICHEM

    Nov 28, 2022, 15:16 PM by
    Full story
  • Overcoming ‘Analysis Paralysis’ in Cell Painting With Artificial Intelligence

    Nov 25, 2022, 01:00 AM by User Not Found
    Bio-IT World | Gone are the days of only measuring single parameters in cell-based experiments. When researchers widen their focus, the end result is an abundant collection of information about the cellular response to perturbations—all nestled within colorful high-content images.
    Full story
  • Atomic Changes: Reshaping our Data Journey in Small Steps

    Nov 22, 2022, 01:00 AM by User Not Found
    Bio-IT World | Stan Gloss, founder of BioTeam, recently sat down with Mike Tarselli, Chief Scientific Officer at TetraScience, to chat about data for Bio-IT World’s Trends from the Trenches podcast and explore the most recent trends in how the life sciences is talking about and thinking about data.
    Full story
  • Element Materials Unveils One of the First and Largest Air Treatment Testing Facilities Designed to Support Indoor Space Public Health Air Quality

    Nov 18, 2022, 09:42 AM by
    Element Materials Technology (Element), a leading global Testing, Inspection and Certification (TIC) company, today unveiled one of the first and largest post-pandemic, commercial bioaerosol testing facilities. It is designed to evaluate the efficacy of aerosolized products to reduce or eliminate indoor airborne organisms and viral particles in habitable spaces such as transportation, hospitals, and schools. The state-of-the-art lab is at the company’s Eagan, Minnesota site.
    Full story
  • Governments should adopt Insulation and Artificial Intelligence measures now for energy security

    Nov 17, 2022, 11:11 AM by
    AI could be used to help secure energy supplies by reducing consumption. It could be a fundamental tool for energy independence + energy security.
    Full story
  • Clinical Exposomics Emerging As A Foundation For Precision Medicine

    Nov 17, 2022, 01:00 AM by User Not Found
    Bio-IT World | High-resolution mass spectrometry methods are in principle “good enough” to put into clinics everywhere to measure low-abundance environmental chemicals and start cataloguing individual exposures. With a focus on the “exposome"—the measure of all the exposures of an individual in a lifetime and how those exposures relate to health—healthcare professionals are examining clinical exposomics as a foundation for precision medicine.
    Full story
  • Shimmer Research Launches the Verisense Digital Health Panel to Create a Universal, Device Independent, Ground Truth Dataset to Accelerate Digital Health

    Nov 16, 2022, 09:30 AM by
    The DHP will systematically collect raw digital health data to facilitate collaboration and accelerate the progress of digital health technologies.
    Full story
  • «
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129 (current)
  • 130
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy